Emerging drugs for premature ejaculation

Expert Opinion on Emerging Drugs

Volumn 11, Issue 1, 2006, Pages 99-109

  Waldinger, Marcel D ^a,b  

^a LEYENBURG HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

5 HT1A receptor; Dapoxetine; Paroxetine; Premature ejaculation; Serotonin; SSRI

Indexed keywords

ANESTHETIC AGENT; CITALOPRAM; CLOMIPRAMINE; DAPOXETINE; FLUOXETINE; LIDOCAINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PAROXETINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PRILOCAINE; ROBALZOTAN; SEROTONIN 1A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; UK 369003;

ACUTE DRUG ADMINISTRATION; BLEEDING; CHRONIC DRUG ADMINISTRATION; DIZZINESS; DRUG EFFICACY; DRUG HALF LIFE; ERECTILE DYSFUNCTION; EXPERIMENTAL RAT; FATIGUE; HUMAN; LIBIDO DISORDER; LOOSE FECES; MALE SEXUAL DYSFUNCTION; MONOTHERAPY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATIENT SATISFACTION; PREMATURE EJACULATION; PRIAPISM; REVIEW; SEROTONINERGIC SYSTEM; SWEATING; SYSTEMATIC REVIEW; TACHYPHYLAXIS; TREMOR; WEIGHT GAIN; WITHDRAWAL SYNDROME; YAWNING;

ADMINISTRATION, ORAL; ANIMALS; BENZYLAMINES; CENTRAL NERVOUS SYSTEM; CLINICAL TRIALS; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; EJACULATION; HALF-LIFE; HUMANS; MALE; NAPHTHALENES; PAROXETINE; PIPERAZINES; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 33645121560     PISSN: 14728214     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728214.11.1.99     Document Type: Review

References (77)

1. ST LAWRENCE JS, MADAKASIRA S: Evaluation and treatment of premature ejaculation: a critical review. Int. J. Psychiatr. Med. (1992) 22:77-97.
2. LAUMANN EO, PAIK A, ROSEN RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA (1999) 281:537-544.
3. GODPODINOFF ML: Premature ejaculation: clinical subgroups and etiology. J Sex Marital Ther. (1989) 15:130.
4. WALDINGER MD: Chapter 15. Rapid Ejaculation. In: Handbook of Clinical Sexuality for Mental Health Professionals. SB Levine (Ed.), Brunner-Routledge, New York, US (2003):257-274.
5. WALDINGER MD: The neurobiological approach to premature ejaculation. J. Urol. (2002) 168:2359-2367.
6. CARANI C, ISIDORI AM, GRANATA A et al.: Multi-center study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J. Clin. Endocrinol. Metab. (2005) 90(12):6472-6479.
7. ABRAHAM K: Ueber Ejaculatio Praecox. Zeitschr. Aerztl. Psychoanal. (1917) 4:171-186.
8. SCHAPIRO B: Premature ejaculation: a review of 1130 cases. J. Urol. (1943) 50:374-379.
9. MASTERS WH, JOHNSON VE: Premature ejaculation. In: Human sexual inadequacy. WH Masters, VE Johnson (Eds), Little Brown, Boston, US (1970):92-115.
10. WALDINGER MD: Lifelong premature ejaculation: from authority based to evidence based medicine. BJU Int. (2004) 93:201-207.
11. WALDINGER MD, ZWINDERMAN AH, SCHWEITZER DH, OLIVIER B: Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int. J. Impot. Res. (2004) 16:369-381.
12. EATON H: Clomipramine in the treatment of premature ejaculation. J. Int. Med. Res. (1973) 1:432-434.
13. GOODMAN RE: An assessment of clomipramine (anafranil) in the treatment of premature ejaculation. J. Int. Med. Res. (1980) 8(Suppl. 3):53-59.
14. PORTO R: Essai en double aveugle de la clomipramine dans l'ejaculation prematuree. Med. Hygiene (1981) 39:1249-1253.
15. GIRGIS SM, EL-HAGGEN S, EL-HERMOUZY S: A double-blind trial of clomipramine in premature ejaculation. Andrologia (1982) 14:364-368.
16. ASSALIAN P: Clomipramine in the treatment of premature ejaculation. J. Sex Res. (1988) 24:213-215.
17. HELLSTROM WJ, GITTELMAN M, ALTHOF S: Dapoxetine HCL for the treatment of premature ejaculation: a Phase II, randomised, double-blind, placebo controlled study. J. Sex. Med. (2004) (Suppl. 1):59.
18. WALDINGER MD, BERENDSEN HHG, BLOK BFM, OLIVIER B, HOLSTEGE G: Premature ejaculation and SSRI-induced delayed ejaculation: the involvement of the serotonergic system. Behav. Brain Res. (1998) 92:111-118.
19. AMERICAN PSYCHIATRIC ASSOCIATION: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. APA, Washington DC, USA (1987).
20. MONTAGUE DK, JAROW J, BRODERICK GA et al.: AUA guideline on the pharmacologic management of premature ejaculation. J. Urol. (2004) 172:290-294.
21. WALDINGER MD: Relevance of an evidence-based ejaculation time cutoff point for neurobiological research of premature ejaculation. J. Comp. Neurol. (2005) 493:46-50.
22. WALDINGER MD: Lifelong premature ejaculation: current debate on definition and treatment. J. Men's Health & Gender (2005) 2:333-338.
23. WALDINGER MD: Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int. J. Impot. Res. (2003) 15:309-313.
24. WALDINGER MD, HENGEVELD MW, ZWINDERMAN AH: Paroxetine treatment of premature ejaculation: a double-blind, randomised, placebo-controlled study. Am. J. Psychiatry (1994) 151:1377-1379.
25. WALDINGER MD, OLIVIER B: Selective serotonin re-uptake inhibitors (SSRIs) and sexual side effects: differences in delaying ejaculation. In: Advances in Preclinical and Clinical Psychiatry, Vol. I. Fluvoxamine: established and emerging roles in psychiatric disorders. E Sacchetti, EP Spano (Eds), Excerpta Medica, Milan, Italy (2000):117-130.
26. WALDINGER MD: Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment. World J. Urol. (2005) 23:102-108.
27. PATTIJ T, DE JONG T, UITTERDIJK A et al.: Individual differences in male rat ejaculatory behavior: searching for models to study ejaculation disorders. Eur. J. Neurosci. (2005) 22:724-734.
28. WALDINGER MD, OLIVIER B: Animal models of premature and retarded ejaculation. World J. Urol. (2005) 23:115-118.
29. OLIVIER B, CHAN JS, PATTIJ T et al.: Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions? Int. J. Impot. Res (2005).
30. PATTIJ T, OLIVIER B, WALDINGER MD: Animal models of ejaculatory behaviour. Curr. Pharm. Des. (2005) 11:4069-4077.
31. WALDINGER MD, QUINN P, DILLEEN M, MUNDAYAT R, SCHWEITZER DH, BOOLELL M: A multi-national population survey of intravaginal ejaculation latency time. J. Sex. Med. (2005) 2:492-497.
32. WALDINGER MD, ZWINDERMAN AH, OLIVIER B, SCHWEITZER DH: Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data. J. Sex. Med. (2005) 2:498-507.
33. WALDINGER MD, HENGEVELD MW, ZWINDERMAN AH, OLIVIER B: An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation. Int. J. Psychiatry Clin. Practice (1998) 2:287-293.
34. WALDINGER MD, SCHWEITZER DH, OLIVIER B: On-demand SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. J. Sex. Med. (2005) 2:120-130.
35. WALDINGER MD: Drug treatment of premature ejaculation: pharmacodynamic and pharmacokinetic paradigms. Drug Discovery Today: Therapeutic Strategies (2005) 2:37-40.
36. 1A receptor antagonist robalzotan enhances SSRI-induced ejaculation delay in the rat. Br. J. Pharmacol. (2003) 138(Suppl. 1):PO32.
37. DE JONG TR, PATTIJ T, VEENING JG et al.: Citalopram combined with WAY 100635 inhibits ejaculation and ejaculation-related Fos immunoreactivity. Eur. J. Pharmacol. (2005) 509:49-59.
38. ALTHOF SE: Psychological treatment strategies for rapid ejaculation: rationale, practical aspects, and outcome. World J. Urol. (2005) 23:89-92.
39. HARTMANN U, SCHEDLOWSKI M, KRUGER THC: Cognitive and partner-related factors in rapid ejaculation: differences between dysfunctional and functional men. World J. Urol. (2005) 23:93-101.
40. SYMONDS T, ROBLIN D, HART K, ALTHOF S: How does premature ejaculation impact a man's life? J. Sex Marital Ther. (2003) 29:361-370.
41. BYERS ES, GRENIER G: Premature or rapid ejaculation: heterosexual couples' perceptions of men's ejaculatory behaviour. Arch. Sex Behav. (2003) 32:261-270.
42. ASSALIAN P: Guidelines for the pharmacothetapy of premature ejaculation. Wrold J. Urol. (2005) 23:127-129.
43. WALDINGER MD, OLIVIER B: Utility of selective serotonin re-uptake inhibitors in premature ejaculation. Curr. Opin. Investig. Drugs (2004) 5:743-747.
44. BERKOVITCH M, KERESTECI AG, KOREN G: Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. J. Urol. (1995) 154:1360-1361.
45. BUSATO W, GALINDO CC: Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. BJU Int. (2004) 93:1018-1021.
46. WEINRIEB RM, AURIACOMBE M, LYNCH KG, LEWIS JD: Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin. Drug Saf. (2005) 4:337-344.
47. AHMAD S: Paroxetine-induced priapism. Arch. Intern. Med. (1995) 155:645.
48. RAND EH: Priapism in a patient taking sertraline. J. Clin. Psychiatry (1998) 59:538.
49. FAVA M, JUDGE R, HOOG SL, NILSSON ME, KOKE SC: Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. J. Clin. Psychiatry (2000) 61:863-867.
50. DITTO KE: SSRI discontinuation syndrome; awareness as an approach to prevention. Postgrad. Med. (2003) 114:79-84.
51. BLACK K, SHEA C, DURSUN S, KUTCHER S: Selective serotonin re-uptake inhibitor discontinuation syndrome; proposed diagnostic criteria. J. Psychiatry Neurosci. (2000) 25:255-261.
52. SEGRAVES RT, SARAN A, SEGRAVES K, MAGUIRE E: Clomipramine versus placebo in the treament of premature ejaculation: a pilot study. J. Sex Marital Ther. (1993) 19:198-200.
53. HAENSEL SM, ROWLAND DL, KALLAN KTHK, SLOB AK: Clomipramine and sexual function in men with premature ejaculation and controls. J. Urol. (1996) 156:1310-1315.
54. STRASSBERG DS, DE GOUVEIA BRAZAO CA, ROWLAND DL, TAN P, SLOB AK: Clomipramine in the treatment of rapid (premature) ejaculation. J. Sex Marital Ther. (1999) 25:89-101.
55. KIM SW, PAICK JS: Short term analysis of the effects of as needed use of sertraline at 5 pm for the treatment of premature ejaculation. Urology (1999) 54:544-547.
56. MCMAHON CG, TOUMA K: Treatment of premature ejaculation with paroxetine hydrochloride. Int. J. Impot. Res. (1999) 11:241-245.
57. ABDEL-HAMID IA, EL NAGGAR EA, EL GILANY AH: Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int. J. Impot. Res. (2001) 13:41-45.
58. CHIA SJ: Management of premature ejaculation - a comparison of treatment outcome in patients with and without erectile dysfunction. Int. J. Androl. (2002) 25:301-305.
59. SALONIA A, MAGA T, COLOMBO R et al.: A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J. Urol. (2002) 168:2486-2489.
60. WALDINGER MD, ZWINDERMAN AH, OLIVIER B: On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. Eur. Urol. (2004) 46:510-516.
61. CHEN J, MABJEESH NJ, MATZKIN H, GREENSTEIN A: Efficacy of sildenafil as adjuvant therapy to selective serotonin re-uptake inhibitor in alleviating premature ejaculation. Urology (2003) 61:197-200.
62. MCMAHON CG, STUCKEY B, ANDERSEN ML: Efficacy of viagra sildenafil citrate in men with premature ejaculation. J. Sex. Med. (2005) 2:368.
63. AVERSA A, MAZZILLI F, ROSSI T, DELFINO M, ISIDORI AM, FABBRI A: Effects of sildenafil (Viagra™) administration on seminal parameters and postejaculatory refractory time in normal males. Hum. Reprod. (2000) 15:131-134.
64. MONDAINI N, PONCHIETTI R, MUIR GH et al.: Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time. Int. J. Impot. Res. (2003) 15:225-228.
65. OLIVIER B, VAN OORSCHOT R, WALDINGER MD: Serotonin, serotonergic receptors, selective serotonin re-uptake inhibitors and sexual behaviour. Int. Clin. Psychopharmacol. (1998) 13(Suppl. 6):9-14.
66. FULLER RW: Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. (1994) 55:163-167.
67. DE MONTIGNY C, BLIER P, CAILLE G, KOUASSI E: Pre- and postsynaptic effects of zimelidine and norzimelidine on the serotoninergic system: single cell studies in the rat. Acta Psychiat. Scand. (1981) 63(Suppl. 290):79-90.
68. MOS J, MOLLET I, TOLBOOM JT, WALDINGER MD, OLIVIER B: A comparison of the effects of different serotonin re-uptake blockers on sexual behaviour of the male rat. Eur. Neuropsychopharmacol. (1999) 9:123-135.
69. BLIER P, DE MONTIGNY C: Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J. Neurosci. (1983) 3:1270-1278.
70. CHAPUT Y, BLIER P, DE MONTIGNY C: In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotoninergic terminals. J. Neurosci. (1986) 6:2796-2801.
71. BLIER P, CHAPUT Y, DE MONTIGNY C: Long-term 5-HT re-uptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. (1988) 337:246-254.
72. CANTOR J, BINIK I, PFAUS JG: Chronic fluoxetine inhibits sexual behaviour in the male rat: reversal with oxytocin. Psychopharmacology (1999) 144:355-362.
73. FRANK JL, HENDRICKS SE, OLSON CH: Multiple ejaculations and chronic fluoxetine: effects on male rat copulatory behaviour. Pharmacol. Biochem. Behav. (2000) 66:337-342.
74. WALDINGER MD, VAN DE PLAS A, PATTIJ T et al.: The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology (2002) 160:283-289.
75. 1B receptor antagonist critically depends on the dose of citalopram. Eur. J. Pharmacol. (2000) 397:63-74.
76. JOHANSSON L, SOHN D, THORBERG SO et al.: The pharmacological characterization of a novel selective 5-hydroxytryptamine 1A receptor antagonist, NAD-299. J. Pharmacol. Exp. Ther. (1997) 283:216-225.
77. DE JONG TR, PATTIJ T, VEENING JG, WALDINGER MD, COOLS AR, OLIVIER B: Effects of chronic selective serotonin re-uptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine. Psychopharmacol. (Berl) (2005) 179:509-515.